Full-Time
Manager – Medical Affairs
Confirmed live in the last 24 hours
Azurity Pharmaceuticals
201-500 employees
Develops specialized formulations of medicines
Mid
Atlanta, GA, USA
Hybrid work model: 2 days from home, 3 days in the office.
- Doctoral-level qualification (PharmD, PhD, MD) preferred, Master’s in a related field and 3+ years relevant experience may substitute.
- A thorough understanding of the science and medical standards of care are essential.
- Successful completion of pre-employment screening
- 3+ years pharmaceutical or bio-tech industry experience
- Ability to communicate highly scientific and technical medical information
- Excellent communication / interpersonal skills / passion for excellence
- Strong writing skills with demonstrated medical communications experience preferred
- Demonstrated leadership ability
- Effective administrative / organizational skills
- Atlanta or Woburn home office-based preferred
- Effectively communicate and proactively lead the dissemination of evidence generation activities from the Medical Affairs organization, including the development and execution of Azurity’s publication strategy
- Lead cross-functional team meetings and drive the production of scientific communications materials, often under tight timelines
- Ensure that submitted materials are accurate, compliant, balanced, and of the highest quality
- Develop, manage and provide input on several key programs/new initiatives within Azurity Medical Affairs, including manuscripts/publications, patient-focused materials, training materials, payer market materials, content for Advisory Board/Steering Committee meetings, dossier development, HEOR, Sales training programs, Azurity policies/SOPs and other materials required for Medical launch excellence
- Manage external vendors and ensure that all materials are developed in a cost-effective manner and are consistent with the strategic thinking for a given product
- Serve as Medical Affairs lead on all product reviews/assessments for lifecycle management (LCM) opportunities led by the Franchise Portfolio Management Heads and provide recommendation on behalf of Medical Affairs for all LCM review requests
- Evaluate the established safety and efficacy profile of potential pipeline assets and FDA-approved product acquisition targets of strategic interest to Azurity
- Educate/train/present key scientific medication and disease state information to internal (e.g., Sales, Marketing, Managed Care) and external stakeholders (e.g., health care practitioners, key thought leaders, advocacy groups, payers) for Azurity products
Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by other pharmaceutical companies. Their products include oral suspensions and other dose forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.
Company Stage
Growth Equity (Venture Capital)
Total Funding
$182.2M
Headquarters
Woburn, Massachusetts
Founded
2000
Simplify's Take
What believers are saying
- FDA approval of Myhibbin™ highlights Azurity's capability to bring unique, patient-centric formulations to market, potentially increasing their market share.
- The acquisition of Slayback Pharma and Arbor Pharmaceuticals expands Azurity's development portfolio, promising a significant number of new medicine launches and enhancing their market position.
- Azurity's focus on underserved patient segments and innovative dose forms can lead to high patient satisfaction and loyalty, driving long-term growth.
What critics are saying
- Product recalls, such as the recent Zenzedi recall, can damage Azurity's reputation and lead to financial losses.
- The specialized nature of their products may limit their market size, making them vulnerable to market fluctuations and competitive pressures.
What makes Azurity Pharmaceuticals unique
- Azurity Pharmaceuticals focuses on developing innovative dose forms of established medicines, addressing unmet needs in the healthcare market, unlike competitors who may focus solely on new drug development.
- Their commitment to creating easier-to-administer formulations, such as oral suspensions, sets them apart by enhancing patient compliance and filling gaps in the pharmaceutical market.
- Azurity's broad therapeutic portfolio and FDA-approved proprietary products ensure they meet stringent regulatory standards, providing a competitive edge in quality and safety.
Help us improve and share your feedback! Did you find this helpful?